Looks like you clickedhttps://www.businesswire.com/news/home/20231108902565/en/Atara-Biotherapeutics-Announces-Primary-Analysis-Data-from-Phase-2-EMBOLD-Clinical-Trial-of-ATA188-in-Non-Active-Progressive-Multiple-Sclerosis
If you do not want to visit that page, you can close this browser tab.
